The World's #1 Mining Property Marketplace

Established 2009 — Connecting Buyers and Sellers Worldwide

Viela Bio Spins Out of MedImmune; Launches with Up to $250 Million Series A Financing from Investor Consortium Led by Boyu Capital, 6 Dimensions Capital, and Hillhouse Capital

GAITHERSBURG, Md., Feb. 28, 2018 /PRNewswire/ — Viela Bio announced today that it has incorporated as an independent inflammation- and autoimmunity-focused biotechnology company after spinning out six molecules from MedImmune, the global biologics research and development arm of…